Category: Oncology/Hematology
Europe Oncology/Hematology
-
Europe Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Breast cancer is the leading form of cancer affecting women in Europe, with approximately 400,000 new cases annually and resulting in 100,000 fatalities. This type of cancer originates from malignant tumors that develop in breast ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Germany Skin Cancer Diagnostics Market Forecast 2023-2030
... melanoma incidence, mandatory skin cancer screening, and substantial healthcare expenditure. MARKET INSIGHTS Data from the cancer registries of the Saarland and Schleswig-Holstein federal states in Germany underscore the rising incidence and mortality trends associated with ... Read More
-
Europe Skin Cancer Diagnostics Market Forecast 2023-2032
... measures, educational initiatives, and public health campaigns undertaken by individuals and healthcare providers. MARKET INSIGHTS Belgium, Poland, Italy, Nordic Countries, Germany, Spain, France, the United Kingdom, and Rest of Europe are assessed for the Europe ... Read More
-
Europe Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - Regional Analysis - by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer), and Country
... Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including ... Read More
-
Europe Radioactive Tracers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Test Type (PET, SPECT, and Others), End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], and Application (Oncology, Pulmonary, Neurology, Cardiology, and Others)
... [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, ... Read More
-
Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibr
... GlobalData’s “Spain Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Italy Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Italy Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Italy Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
EU5 Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroi
... GlobalData’s “EU5 Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the EU5 Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
... 2030 Summary GlobalData’s “United Kingdom Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Embolization Particle Procedures. The databook report provides procedure volumes within segments ... Read More
-
Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), by Disease Indication (CNS Disorders, Cardiovascular, Cancer, Autoimmune Disorders, COVID-19, Others) By End User (Hospitals, Long-term Care Facilities, Research institutes), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Antibodies are used in therapeutic applications for the treatment of diseases such as cancer, autoimmune ... Read More
-
France Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the France market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the France market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More
-
2023 Albania Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for Over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 Romania Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 Netherlands Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 Switzerland Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 France Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . LeadingMarketResearch.com's new study is designed to help current suppliers and ... Read More
-
2023 Belgium Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 Belarus Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Summary This new comprehensive report from LeadingMarketResearch.com is designed to help current suppliers ... Read More
-
2023 Germany Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
... Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . LeadingMarketResearch.com's new study is designed to help current suppliers and ... Read More
-
Europe Pharmacovigilance Market By Service provider (In-house, Contract Outsourcing), By Product Life Cycle (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, Others), By End-Use (Pharmaceuticals & Biotechnology Companies, Medical Device Manufacturers, Others), By Country, Competition, Forecast & Opportunities, 2028
... Monitoring, EHR Mining), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, Others), By End-Use (Pharmaceuticals & Biotechnology Companies, Medical Device Manufacturers, Others), By Country, ... Read More
-
HER-2 Negative Breast Cancer Market, By Type of Treatment (Chemotherapy, Radiation, Hormonal Therapy, and Other Types of Treatments) and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Outlook, and Opportunity Analysis, 2023 - 2030 HER2-negative negative breast cancer means that the cancerous cells do not contain high levels of the protein HER2. Cancer cells that are HER2 negative may grow more slowly ... Read More
-
Cancer Supportive Care Products Market, By Drug Class (Nonsteroidal Anti – Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor), By Indication(Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, ... Read More
-
2023 Hungary Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
Research Assistance
